XML 29 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Marketable Securities
12 Months Ended
Dec. 31, 2017
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
Marketable Securities
Available-for-sale marketable securities and cash and cash equivalents consist of the following (in thousands):
 
December 31, 2017
 
Amortized
Cost Value
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Cash and cash equivalents:
 

 
 

 
 

 
 

Cash
$
73,302

 
$

 
$

 
$
73,302

Money market
325

 

 

 
325

Domestic corporate commercial paper
44,937

 

 

 
44,937

Total
$
118,564

 
$

 
$

 
$
118,564

Marketable securities:
 

 
 

 
 

 
 

Domestic corporate debt securities
$
207,320

 
$
1

 
$
(235
)
 
$
207,086

Domestic corporate commercial paper
29,844

 

 
(7
)
 
29,837

Agency bonds
74,842

 

 
(73
)
 
74,769

Total
$
312,006

 
$
1

 
$
(315
)
 
$
311,692


 
December 31, 2016
 
Amortized
Cost Value
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair
Value
Cash and cash equivalents:
 

 
 

 
 

 
 

Cash
$
77,443

 
$

 
$

 
$
77,443

Money market funds
173,631

 

 

 
173,631

Domestic corporate commercial paper
5,487

 

 

 
5,487

Domestic corporate debt securities
2,006

 

 

 
2,006

Total
$
258,567

 
$

 
$

 
$
258,567

Marketable securities:
 

 
 

 
 

 
 

Domestic corporate debt securities
$
19,317

 
$

 
$
(2
)
 
$
19,315

Domestic corporate commercial paper
31,852

 
78

 

 
31,930

Asset-backed securities
22,639

 

 
(4
)
 
22,635

Total
$
73,808

 
$
78

 
$
(6
)
 
$
73,880


There were no debt securities that had been in an unrealized loss position for more than 12 months as of December 31, 2017 or December 31, 2016. There were 38 debt securities in an unrealized loss position for less than 12 months at December 31, 2017 and there were 13 debt securities that had been in an unrealized loss position for less than 12 months at December 31, 2016. The aggregate unrealized loss on these securities as of December 31, 2017 and 2016 was approximately $315 thousand and $6 thousand, respectively, and the fair value was $299.2 million and $35.7 million, respectively. The Company considered the decline in market value for these securities to be primarily attributable to current economic conditions. As it was not more likely than not that the Company would be required to sell these securities before the recovery of their amortized cost basis, which may be maturity, the Company did not consider these investments to be other-than-temporarily impaired as of December 31, 2017 and 2016.
As of December 31, 2017, marketable securities consisted of investments that mature within one year, with the exception of certain corporate debt securities and agency bonds, which have maturities within 2 years and an aggregate fair value of $177.0 million.